Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A1 | P18405 | 1/20 | 0.57 |
| ▸ | EPHX2 | P34913 | 5/20 | 0.51 |
| ▸ | NAMPT | P43490 | 3/20 | 0.51 |
| ▸ | SCD5 | Q86SK9 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.45 |
| ▸ | DRD2 | P14416 | 3/20 | 0.45 |
| ▸ | DRD4 | P21917 | 3/20 | 0.45 |
| ▸ | DRD3 | P35462 | 3/20 | 0.45 |
| ▸ | SMYD3 | Q9H7B4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23136089 | 0.88 | SRD5A1 (0.60) | SRD5A1EPHX2NAMPTSCD5HRH3 | |
| Hydrochloric Acid SCHEMBL2775020 | 0.88 | SRD5A1 (0.54) | SRD5A1EPHX2NAMPTSCD5CHRM2 | |
| SCHEMBL27805791 | 0.86 | SRD5A1 (0.49) | SRD5A1EPHX2NAMPTHRH3SMYD3 | |
| SCHEMBL27805792 | 0.86 | SRD5A1 (0.49) | SRD5A1EPHX2NAMPTHRH3SMYD3 | |
| SCHEMBL27805800 | 0.86 | EPHX2 (0.50) | SRD5A1EPHX2NAMPTHRH3SMYD3 | |
| SCHEMBL27805799 | 0.86 | EPHX2 (0.50) | SRD5A1EPHX2NAMPTHRH3SMYD3 | |
| Hydrochloric Acid SCHEMBL2777270 | 0.85 | HRH3 (0.49) | SRD5A1EPHX2NAMPTHRH3SMYD3 | |
| Hydrochloric Acid SCHEMBL2773554 | 0.85 | HRH3 (0.49) | SRD5A1EPHX2NAMPTHRH3SMYD3 | |
| Hydrochloric Acid SCHEMBL2773459 | 0.82 | EPHX2 (0.51) | SRD5A1EPHX2 | |
| SCHEMBL14412821 | 0.80 | EPHX2 (0.57) | SRD5A1EPHX2NAMPTSCD5CHRM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2604601-A1 | HETERO RING COMPOUND | Astellas Pharma Inc. (JP) | 2013-06-19 | — | — | EP | disclosed |